Literature DB >> 10886237

IVIG-bound IgG and IgM cloned by phage display from a healthy individual reveal the same restricted germ-line gene origin as in autoimmune thrombocytopenia.

M Hoffmann1, M M Uttenreuther-Fischer, H Lerch, G Gaedicke, P Fischer.   

Abstract

Intravenous immunoglobulin preparations (IVIG) have shown positive effects in the treatment of immune defects and autoimmune diseases. It is not clear how IVIG interacts with the components of the immune system. To investigate this, we cloned previously a large number of phage displayed IgG Fab fragments derived from three patients with autoimmune thrombocytopenia (AITP) that were specifically bound by IVIG molecules. Many of these Fabs reacted with platelets. Sequencing revealed that the most frequently used germ-line gene segments of all IVIG-bound Fabs were identical to those observed for many other autoantibodies. Particularly, the loci 3-30 or 3-30/3-30. 5, 3-23 and 3r, 3l, and 2a2 represented the most abundant genes used for the heavy (VH) and light chain V region (VL), respectively. This suggested a specific interaction of IVIG molecules with B cells that present B cell receptors derived from these germ-line genes. In the current study we determined the genetic origin of IVIG-reactive IgG and IgM cloned from a healthy person. A favoured selection of antibodies derived from the same germ-line origins as in AITP was observed. Because 3-30 and 3-23 are the most frequently rearranged VH germ-line gene segments among human B cells, our results suggest that this favoured anti-idiotypic interaction may have an important role for the development and control of the normal B cell repertoire.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886237      PMCID: PMC1905678          DOI: 10.1046/j.1365-2249.2000.01229.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Biased VH gene usage in early lineage human B cells: evidence for preferential Ig gene rearrangement in the absence of selection.

Authors:  S P Rao; J M Riggs; D F Friedman; M S Scully; T W LeBien; L E Silberstein
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

2.  A surface expression vector for antibody screening.

Authors:  F Breitling; S Dübel; T Seehaus; I Klewinghaus; M Little
Journal:  Gene       Date:  1991-08-15       Impact factor: 3.688

3.  Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.

Authors:  C F Barbas; A S Kang; R A Lerner; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

4.  Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families.

Authors:  I Sanz; P Casali; J W Thomas; A L Notkins; J D Capra
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

5.  Platelet-reactive IgG antibodies cloned by phage display and panning with IVIG from three patients with autoimmune thrombocytopenia.

Authors:  P Fischer; N Jendreyko; M Hoffmann; H Lerch; M M Uttenreuther-Fischer; P P Chen; G Gaedicke
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

6.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

7.  Early restriction of the human antibody repertoire.

Authors:  H W Schroeder; J L Hillson; R M Perlmutter
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

8.  Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.

Authors:  P Imbach; H P Wagner; W Berchtold; G Gaedicke; A Hirt; P Joller; C Mueller-Eckhardt; B Müller; E Rossi; S Barandun
Journal:  Lancet       Date:  1985-08-31       Impact factor: 79.321

9.  Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine/anti-myosin antibody V region genes.

Authors:  E E Adderson; A R Shikhman; K E Ward; M W Cunningham
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

10.  Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: a prospective multicenter study.

Authors:  B Imholz; P Imbach; C Baumgartner; W Berchtold; G Gaedicke; E Gugler; A Hirt; W Hitzig; C Mueller-Eckhardt; H P Wagner
Journal:  Blut       Date:  1988-02
View more
  2 in total

Review 1.  HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.

Authors:  Giuseppe Sautto; Nicasio Mancini; Laura Solforosi; Roberta A Diotti; Massimo Clementi; Roberto Burioni
Journal:  Clin Dev Immunol       Date:  2012-05-29

2.  Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.

Authors:  A Razzaque Ahmed; Srinivas Kaveri
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.